SCHEMBL3701985

SCHEMBL3701985

Cc1cccc(S(=O)(=O)c2cc(CN(C)C(=O)OC(C)(C)C)nn2-c2ccccc2Cl)n1

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 6/20 0.43
SLC6A4 P31645 6/20 0.43
SLC16A3 O15427 13/20 0.37
SLC16A1 P53985 12/20 0.37
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3691768 0.90 HTR2C (0.42) HTR2CSLC6A4SLC16A3SLC16A1
SCHEMBL3696893 0.88 SLC16A3 (0.46) HTR2CSLC6A4SLC16A3SLC16A1
SCHEMBL4118797 0.87 SLC16A3 (0.36) HTR2CSLC6A4SLC16A3SLC16A1PDE4B
SCHEMBL3702179 0.85 HTR2C (0.43) HTR2CSLC6A4SLC16A3SLC16A1
SCHEMBL3696612 0.85 HTR2C (0.42) HTR2CSLC6A4SLC16A3SLC16A1
SCHEMBL3701580 0.84 HTR2C (0.44) HTR2CSLC6A4SLC16A3SLC16A1
SCHEMBL3696906 0.82 HTR2C (0.43) HTR2CSLC6A4SLC16A3SLC16A1
SCHEMBL3701987 0.82 SLC16A3 (0.36) SLC16A3SLC16A1PDE4B
SCHEMBL3706235 0.81 HTR2C (0.49) HTR2CSLC6A4SLC16A3SLC16A1
SCHEMBL3698155 0.80 HTR2C (0.41) HTR2CSLC6A4SLC16A3SLC16A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2190822-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2010-06-02 EP disclosed
WO-2009041705-A9 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2009-08-13 WO disclosed
WO-2009041705-A2 5-MEMBERED HETEROCYCLIC COMPOUNDS AS PROTON PUMP INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-04-02 WO disclosed